A self-management app in a digital treat-to-target gout-care approach: the ReMonit Gout feasibility study
Authors' conclusion
The overall feasibility of the Urika app and the study logistics were satisfactory.
Study context
- Population
- Patients with gout initiating urate-lowering therapy (ULT) in specialized healthcare (secondary care)males aged 29–71 years
- Participants
- 21 patients
- Outcome
- Overall feasibility: proportion of predefined feasibility criteria (technical, operational, trial, clinical outcome collection) achieved
- Follow-up
- 3 months
Methodological detailssingle-group, 3 months, predefined feasibility criteria (acceptable if ≥ 70% achieved)
- Single-group
- 3 months
- Predefined feasibility criteria (acceptable if ≥ 70% achieved)
Main finding
As reported in the abstract
Predefined feasibility criteria achieved (acceptable if ≥ 70%)
Predefined feasibility criteria achieved
27 of 31
87%
Further findings
Satisfaction with the app ≥ 8 on a 0-10 NRS
- Patients rating app satisfaction ≥ 8 (0-10 NRS)
- 85%
Satisfied/very satisfied with the gout treatment
- Patients satisfied/very satisfied with gout treatment
- 90%
Safety
- No safety issues identified in this small sample
Original publication
A self-management app in a digital treat-to-target gout-care approach: the ReMonit Gout feasibility study. Scand J Rheumatol. Published 13 August 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →